As of 2023, the import value of unsaturated acyclic and cyclic monocarboxylic acids to China was not explicitly stated, but we observe a consistent upward trend from 2024 onwards, commencing at $682.53 million and reaching $708.9 million by 2028.

Year-on-year, the forecasts indicate moderate growth rates with slight annual increases in import value, depicting stable but incremental market demand. The five-year compound annual growth rate (CAGR) further emphasizes this gradual uptrend.

Looking ahead, key trends to monitor include:

Potential fluctuations in global raw material prices influencing import costs.
China's industrial and economic policies that may impact import needs.
Innovation and demand shifts in end-user industries such as pharmaceuticals and plastics.